Page Loader Image
  • About Us
  • Knowledge Hub
  • Resources
  • Events
  • In the media
  • Contact
Public Pharma For Europe
Public Pharma For Europe
Public Pharma For Europe
  • About Us
  • Knowledge Hub
  • Resources
  • Events
  • In the media
  • Contact
Public Pharma For Europe
  • About Us
  • Knowledge Hub
  • Resources
  • Events
  • In the media
  • Contact

Leven van Erik (55) uit Oosterhesselen gered door experimenteel medicijn UMCG. ‘Kritiek farmalobby tenenkrommend’

Read More »

In Defense of Public Pharma at the University Medical Center Groningen: A Statement of Solidarity

Read More »

Para confrontar a Big Pharma, Farmacêuticas Públicas

Read More »

Shortage of antiseizure medication in Germany: How big is the problem?

Read More »

What a $2 Million Per Dose Gene Therapy Reveals About Drug Pricing

Read More »

Prix des médicaments : “Le modèle d’affaire de l’industrie pharmaceutique sert à maximiser ses profits”

Read More »

Public Pharma: What It Is and Why It’s Important?

Read More »

Technology transfer, intellectual property, and the fight for the soul of WHO

Read More »

Reclaiming medicines and health innovation for our health

Read More »

What are countries doing to tackle worsening drug shortages

Read More »
Page1 Page2 Page3 Page4 Page5

Keep In Touch

MENU

  • About us
  • Events
  • Knowledge Hub
  • Resources
  • Contact